Variable | Value or No. of patients(%) |
---|---|
Sex | |
Male | 48 (71.6%) |
Female | 19 (28.4%) |
Median age (years, range) | 59 (34~ 80) |
Current smoker | |
Yes | 43 (64.2%) |
No | 24 (35.8%) |
Tumor type | |
Recurrences | 54 (80.6%) |
Metastases | 10 (14.9%) |
New primary tumors | 3 (4.5%) |
Pathologic type | |
NSCLC | 36 (53.7%) |
SCLC | 31 (46.3%) |
Prior thoracic surgery | |
Yes | 17 (25.4%) |
No | 50 (74.6%) |
ECOG status before Re-RT | |
0–1 | 61 (91.0%) |
2 | 6 (9.0%) |
Chemotherapy | |
Yes | 19 (28.4%) |
No | 48 (71.6%) |
Initial RT technique | |
Conventional | 65 (97.0%) |
SBRT | 2 (3.0%) |
Re-RT technique | |
Conventional | 60 (89.6%) |
SBRT | 7 (10.4%) |
Re-RT location | |
Central | 47 (70.1%) |
Peripheral | 20 (29.9%) |
Re-RT location | |
In field | 33 (49.3%) |
Outside | 34 (50.7%) |
Median time to Re-RT(months, range) | 16 (2–96) |
Median follow-up(months, range) | 9(4–76) |